Article
Mary M. Bridgeman, PharmD, BCPS, CGP, discusses OTC recommendations for OIC symptoms.
Mary M. Bridgeman, PharmD, BCPS, CGP, discusses OTC recommendations for OIC symptoms.
Chenodiol, First Treatment for Cerebrotendinous Xanthomatosis, Receives FDA Approval
Chenodiol, First Treatment for Cerebrotendinous Xanthomatosis, Receives FDA Approval
2 Commerce Drive
Cranbury, NJ 08512